Cell viscosity influences hematogenous dissemination and metastatic extravasation of tumor cells
Ontology highlight
ABSTRACT:
PROVIDER: PRJEB81890 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| ERR13914504.fastq.gz | Fastqsanger.gz | |||
| ERR13914505.fastq.gz | Fastqsanger.gz | |||
| ERR13914506.fastq.gz | Fastqsanger.gz | |||
| ERR13914507.fastq.gz | Fastqsanger.gz | |||
| ERR13914508.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 18 |
Similar Datasets
Project description:Metastases arise from a multi-step process during which tumor cells change their mechanics in response to microenvironmental cues. While such mechanical adaptability could influence metastatic success, how tumor cell mechanics directly impacts intravascular behavior of circulating tumor cells (CTCs) remains poorly understood. In the present study, we demonstrate how the deformability of CTCs affects hematogenous dissemination and identify the mechanical profiles that favor metastatic extravasation. Combining intravital microscopy with CTC-mimicking elastic beads and mechanically-tuned tumor cells, we demonstrate that the inherent properties of circulating objects dictate their ability to enter constraining vessels. We identify cellular viscosity as the key property that governs CTC circulation and arrest patterns. We further demonstrate that cellular viscosity is required for efficient extravasation and find that properties that favor extravasation and subsequent metastatic outgrowth can be opposite. Altogether, we identify CTC viscosity as a key biomechanical parameter that shapes several steps of metastasis.
2024-11-24 | E-MTAB-14571 | biostudies-arrayexpress
Project description:ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization
| PRJNA1174147 | ENA
Project description:Metastases, which largely rely on hematogenous dissemination of tumor cells via the vascular system, significantly limit prognosis of patients with solid tumors. To colonize distant sites, circulating tumor cells must destabilize the endothelial barrier and transmigrate across the vessel wall. Here we performed a high-content screen to identify drugs that block tumor cell extravasation by testing 3520 compounds on a transendothelial invasion co-culture assay. Hits were further characterized and validated using a series of in vitro assays, a zebrafish model enabling 3-D visualization of tumor cell extravasation, and mouse models of lung metastasis. The initial screen advanced 38 compounds as potential hits, of which 4 compounds enhanced endothelial barrier stability while concurrently suppressing tumor cell motility. Two compounds: niclosamide and forskolin, significantly reduced tumor cell extravasation in zebrafish and niclosamide drastically impaired metastasis in mice. Because niclosamide had not previously been linked with effects on barrier function, we performed single cell RNA sequencing to reveal mechanistic effects of the drug on both tumor and endothelial cells. Importantly, niclosamide affected homotypic and heterotypic signaling critical to intercellular junctions, cell-matrix interactions, and cytoskeletal regulation. Proteomic analysis indicated that niclosamide-treated mice also showed reduced levels of kininogen, the precursor to the permeability mediator bradykinin. Our findings designate niclosamide as an effective drug that restricts tumor cell extravasation through modulation of signaling pathways, chemokines, and tumor-endothelial cell interactions.
2020-11-05 | GSE160915 | GEO
Project description:Three possible metastatic pathways forSister Mary Joseph's nodule (SMJN) have been postulated: hematogenous spread, lymphatic dissemination, and direct invasion. However, detailed analyses of these metastatic pathways, particularly using gene expression profiling, remain notably absent from the literature. we investigated the metastatic patterns of SMJN by performing RNA microarray analysis on the primary tumor and each metastatic site in a case of fallopian tube cancer presenting with SMJN and inguinal lymph node metastasis.
2025-05-26 | GSE297669 | GEO
Project description:How dysregulation of neurodevelopment relates to medulloblastoma (MB), the most common pediatric brain tumor, remains elusive. Here, we uncovered a neurodevelopmental epigenomic program being hijacked to induce MB metastatic dissemination. Unsupervised analyses by integrating publicly available datasets with our newly generated data revealed that SMARCD3/BAF60C regulates DAB1-mediated Reelin signaling in Purkinje cell migration and MB metastasis by orchestrating cis-regulatory elements (CREs) at the DAB1 locus. We further identified that a core set of transcription factors, enhancer of zeste homolog 2 (EZH2) and nuclear factor I X (NFIX), coordinates with the CREs at the SMARCD3 locus to form a chromatin hub for controlling SMARCD3 expression in the developing cerebellum and metastatic MB. Elevated SMARCD3 activates Reelin/DAB1-mediated Src kinase signaling, resulting in MB response to Src inhibition. These data deepen our understanding of how neurodevelopmental programming influences disease progression and provide a potential therapeutic option for MB patients.
2023-02-28 | GSE194216 | GEO
Project description:How dysregulation of neurodevelopment relates to medulloblastoma (MB), the most common pediatric brain tumor, remains elusive. Here, we uncovered a neurodevelopmental epigenomic program being hijacked to induce MB metastatic dissemination. Unsupervised analyses by integrating publicly available datasets with our newly generated data revealed that SMARCD3/BAF60C regulates DAB1-mediated Reelin signaling in Purkinje cell migration and MB metastasis by orchestrating cis-regulatory elements (CREs) at the DAB1 locus. We further identified that a core set of transcription factors, enhancer of zeste homolog 2 (EZH2) and nuclear factor I X (NFIX), coordinates with the CREs at the SMARCD3 locus to form a chromatin hub for controlling SMARCD3 expression in the developing cerebellum and metastatic MB. Elevated SMARCD3 activates Reelin/DAB1-mediated Src kinase signaling, resulting in MB response to Src inhibition. These data deepen our understanding of how neurodevelopmental programming influences disease progression and provide a potential therapeutic option for MB patients.
2023-02-28 | GSE194215 | GEO
Project description:How dysregulation of neurodevelopment relates to medulloblastoma (MB), the most common pediatric brain tumor, remains elusive. Here, we uncovered a neurodevelopmental epigenomic program being hijacked to induce MB metastatic dissemination. Unsupervised analyses by integrating publicly available datasets with our newly generated data revealed that SMARCD3/BAF60C regulates DAB1-mediated Reelin signaling in Purkinje cell migration and MB metastasis by orchestrating cis-regulatory elements (CREs) at the DAB1 locus. We further identified that a core set of transcription factors, enhancer of zeste homolog 2 (EZH2) and nuclear factor I X (NFIX), coordinates with the CREs at the SMARCD3 locus to form a chromatin hub for controlling SMARCD3 expression in the developing cerebellum and metastatic MB. Elevated SMARCD3 activates Reelin/DAB1-mediated Src kinase signaling, resulting in MB response to Src inhibition. These data deepen our understanding of how neurodevelopmental programming influences disease progression and provide a potential therapeutic option for MB patients.
2023-02-28 | GSE194213 | GEO
Project description:Cancer cell extravasation is a key step of the metastatic cascade and an attractive therapeutic opportunity. Early steps in cancer cell extravasation require formation of tentacle-like protrusions called invadopodia that physically breach the endothelial barrier and degrade extracellular matrix (ECM). However, the mechanisms by which invadopodia-specific proteases such as MT1-MMP are called to invadopodia are unclear. In integrin-activated metastatic breast cancer cells, MT1-MMP was found to associate with plectin, a cytoskeletal linker protein, and vimentin, an intermediate filament (IF) protein. Interestingly, complex formation between plectin MT1-MMP immediately launches invadopodia formation, a subtype we termed iplectin (i=invadopodial). iPlectin (complexes of plectin and MT1-MMP) and vimentin cooperate to deliver and anchor this form of MT1-MMP to invadopodia. Genetic depletion of plectin significantly reduced invadopodia formation and significantly reduced cell invasion in vitro. To ascertain the effects of depleted plectin on metastatic behavior, in vivo extravasation efficiency assays and intravital imaging methods were performed. These assays revealed iplectin to be a key component of invadopodia ultrastructure; loss of plectin abrogated cancer cell extravasation rates. Pharmacological inhibition of plectin using the novel small molecule Plecstatin-1 (PST-1) altered vimentin and microtubule networks and altered MT1-MMP delivery to F-actin puncta, presumably due to inhibition of iplectin. In terms of metastasis dynamics, PST-1 treatment reduced invadopodia formation and extravasation rates. Hence, iplectin is responsible for MT1-MMP being called to invadopodia and the most therapeutically relevant form of plectin.
2025-03-28 | PXD039276 | Pride
Project description:Hijacking a neurodevelopmental epigenomic program in metastatic dissemination of medulloblastoma
| PRJNA799747 | ENA
Project description:Phylogenetic Analyses of Melanoma Reveal Complex Patterns of Metastatic Dissemination
| PRJNA288058 | ENA